Repetto HA (2005) Long-term course and mechanisms of progression of renal disease in hemolytic uremic syndrome. Kidney Int 97:S102–S106. https://doi.org/10.1111/j.1523-1755.2005.09717.x
Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso JD, Amoreo OR (1997) Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol 11:156–160. https://doi.org/10.1007/s004670050248
Article CAS PubMed Google Scholar
Siegler RL, Milligan MK, Burningham TH, Christofferson RD, Chang SY, Jorde LB (1991) Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome. J Pediatr 118:195–200. https://doi.org/10.1016/s0022-3476(05)80482-2
Article CAS PubMed Google Scholar
Spinale JM, Ruebner RL, Copelovitch L, Kaplan BS (2013) Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr Nephrol 28:2097–2105. https://doi.org/10.1007/s00467-012-2383-6
Alconcher LF, Lucarelli LI, Bronfen S, Villarreal F (2023) Kidney sequelae in 281 Shiga toxin-producing Escherichia coli-hemolytic uremic syndrome patients after a median follow-up of 12 years. Pediatr Nephrol. https://doi.org/10.1007/s00467-023-06183-7
Pundzienė B, Dobilienė D, Čerkauskienė R, Mitkienė R, Medzevičienė A, Darškuvienė E, Jankauskienė A (2015) Long-term follow-up of children with typical hemolytic uremic syndrome. Medicina 51:146–151. https://doi.org/10.1016/j.medici.2015.06.004
Balestracci A, Meni Battaglia L, Toledo I, Martin SM, Puyol I, Beaudoin L, Robledo NL (2021) Diagnostic sensitivity of extended renal and hematologic criteria to define hemolytic uremic syndrome. Arch Argent Pediatr 119:238–244. https://doi.org/10.5546/aap.2021.eng.238
Ardissino G, Possenti I, Tel F, Testa S, Paglialonga F (2014) Time to change the definition of hemolytic uremic syndrome. Eur J Intern Med 25:e29. https://doi.org/10.1016/j.ejim.2013.12.002
Coccia P, Ramírez F, Suárez A, Alconcher L, Balestracci A et al (2021) Acute peritoneal dialysis, complications and outcomes in 389 children with STEC-HUS: a multicenter experience. Pediatr Nephrol 36:1597–1606. https://doi.org/10.1007/s00467-020-04876-x
Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS, National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (2003) National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416–1421. https://doi.org/10.1542/peds.111.6.1416
Cubillos CMP, Del Salas P, Zambrano PO (2015) Microalbuminuria in pediatric patients diagnosed with hemolytic uremic syndrome. Rev Chil Pediatr 86:92–96. https://doi.org/10.1016/j.rchipe.2015.04.019
Imam AA, Saadeh SA (2022) Evaluation of proteinuria and hematuria in ambulatory setting. Pediatr Clin North Am 69:1037–1049. https://doi.org/10.1016/j.pcl.2022.07.002
Flynn JT, Kaelber DC, Baker-Smith CM, Subcommittee on screening and management of high blood pressure in children et al (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20171904. https://doi.org/10.1542/peds.2017-3035
Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263. https://doi.org/10.1542/peds.58.2.259
Article CAS PubMed Google Scholar
Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, Avila Edwards KC, Eneli I, Hamre R, Joseph MM, Lunsford D, Mendonca E, Michalsky MP, Mirza N, Ochoa ER, Sharifi M, Staiano AE, Weedn AE, Flinn SK, Lindros J et al (2023) Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics 151:e2022060640. https://doi.org/10.1542/peds.2022-060640
Caletti MG, Missoni M, Vezzani C, Grignoli M, Piantanida JJ, Repetto HA, Exeni R, Rasse SM (2011) Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy. Pediatr Nephrol 26:1247–1254. https://doi.org/10.1007/s00467-011-1867-0
Caletti MG, Balestracci A, Missoni M, Vezzani C (2013) Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome. Pediatr Nephrol 28:745–750. https://doi.org/10.1007/s00467-012-2374-7
KDIGO CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150. https://www.kisupplements.org/article/S2157-1716(16)30005-3/fulltext
Brunner K, Bianchetti MG, Neuhaus TJ (2004) Recovery of renal function after long-term dialysis in hemolytic-uremic syndrome. Pediatr Nephrol 19:229–231. https://doi.org/10.1007/s00467-003-1337-4
Borkar D, Schutt C, Verghese P (2018) Renal recovery years after initial diagnosis of hemolytic uremic syndrome. Clin Pediatr 57:861–864. https://doi.org/10.1177/0009922817732621
Bonthuis M, Harambat J, Bérard E, Cransberg K, Duzova A, Garneata L et al (2018) Recovery of kidney function in children treated with maintenance dialysis. Clin J Am Soc Nephrol 13:1510–1516. https://doi.org/10.2215/CJN.01500218
Article PubMed PubMed Central Google Scholar
Ruggenenti P, Perticucc E, Cravedi P, Gambara V, Costantini M, Sharma SK, Perna A, Remuzzi G (2008) Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 19:1213–1224. https://doi.org/10.1681/ASN.2007090970
Article PubMed PubMed Central Google Scholar
Caletti MG, Lejarraga H, Kelmansky D, Missoni M (2004) Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome. Pediatr Nephrol 19:1148–1152. https://doi.org/10.1007/s00467-004-1516-y
Van Dyck M, Proesmans W (2004) Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome. Pediatr Nephrol 19:688–690. https://doi.org/10.1007/s00467-004-1451-y
Monteverde ML, Panero N, Chaparro AB, Locane F, Sarkis C, Mattio SA, Ibañez JP (2023) A decrease in the incidence of Shiga toxin-related hemolytic uremic syndrome as a cause of kidney transplantation at an argentine referral center. Pediatr Transplant 27:e14489. https://doi.org/10.1111/petr.14489
Article CAS PubMed Google Scholar
Ardissino G, Testa S, Daccò V, Paglialonga F, Viganò S, Felice-Civitillo C, Battaglino F, Bettinelli A, Bordugo A, Cecchetti V, De Pascale S, La Manna A, Li Volti S, Maringhini S, Montini G, Pennesi M, Peratoner L (2012) Puberty is associated with increased deterioration of renal function in patients with CKD: data from the ItalKid Project. Arch Dis Child 97:885–888. https://doi.org/10.1136/archdischild-2011-300685
Gunta SS, Mak RH (2013) Is obesity a risk factor for chronic kidney disease in children? Pediatr Nephrol 28:1949–1956. https://doi.org/10.1007/s00467-012-2353-z
Small G, Watson AR, Evans JH, Gallagher J (1999) Hemolytic uremic syndrome: defining the need for long-term follow-up. Clin Nephrol 52:352–356
Monet-Didailler C, Godron-Dubrasquet A, Madden I, Delmas Y, Llanas B, Harambat J (2019) Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort. Pediatr Nephrol 34:657–662. https://doi.org/10.1007/s00467-018-4131-z
Rosales A, Hofer J, Zimmerhackl LB, Jungraithmayr TC, Riedl M, Giner T, Strasak A, Orth-Höller D, Würzner R, Karch H, German-Austrian HUS Study Group (2012) Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis 54:1413–1421. https://doi.org/10.1093/cid/cis196
Comments (0)